Beclometasone Dipropionate/Formoterol fumarate Dihydrate/Glycopyrronium Bromide

二丙酸倍氯米松/富马酸福莫特罗二水合物/格隆溴铵

Report date: 2026/05/20 20:02:01

Base Information

Drug NameBeclometasone Dipropionate/Formoterol fumarate Dihydrate/Glycopyrronium Bromide
Drug Alias NameGlycopyrrolate bromide/Formoterol fumarate二丙酸倍氯米松/甘罗溴铵/富马酸福莫特罗BDP/FF/GB二丙酸倍氯米松/富马酸福莫特罗/甘罗溴铵倍氯福格 +[15] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionBeta-2 adrenergic receptor agonistsGlucocorticoid receptor agonistsMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptorBeta-2 adrenergic receptorGlucocorticoid receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Approved Indications in ChinaPulmonary Disease, Chronic Obstructive
Original Approved Country/TerritoryEU
Original Approved Date2017/07/17
Country/TerritoryCzechiaBelgiumBulgaria +[27] 
CombinationsYes Formoterol FumarateBeclometasone DipropionateGlycopyrronium Bromide
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChiesi Farmaceutici SPA
China Registration ClassN/A

Develop Information

Active CompaniesChiesi Farmaceutici SPAChiesi Pharmaceutical Consulting (Shanghai) Co Ltd
Inactive CompaniesUniversity Of Alabama At Birmingham
Active IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Inactive IndicationsN/A

Other Information

ATC CodeR03AL09
Related LinksN/A